SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system,
FREYR Battery (NYSE: FREY) reported better-than-expected earnings results on Monday, but as a pre-revenue company, investors should be paying more attention to its operational update.